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Introduction: Bone remodelling and increased subchondral densification are important in osteoarthritis (OA).
Modifications of bone vascularization parameters, which lead to ischemic episodes associated with hypoxic
conditions, have been suspected in OA. Among several factors potentially involved, leptin and dickkopf-related
protein 2 (DKK2) are good candidates because they are upregulated in OA osteoblasts (Obs). Therefore, in the
present study, we investigated the hypothesis that hypoxia may drive the expression of leptin and DKK2 in OA Obs.
Methods: Obs from the sclerotic portion of OA tibial plateaus were cultured under either 20% or 2% oxygen
tension in the presence or not of 50 nM 1,25-dihydroxyvitamin D3 (VitD3). The expression of leptin, osteocalcin,
DKK2, hypoxia-inducible factor 1α (Hif-1α) and Hif-2α was measured by real-time polymerase chain reaction and
leptin production was measured by enzyme-linked immunosorbent assay (ELISA). The expression of Hif-1α, Hif-2α,
leptin and DKK2 was reduced using silencing RNAs (siRNAs). The signalling pathway of hypoxia-induced leptin was
investigated by Western blot analysis and with mitogen-activated protein kinase (MAPK) inhibitors.
Results: The expression of leptin and DKK2 in Obs was stimulated 7-fold and 1.8-fold, respectively (P <0.05) under
hypoxia. Interestingly, whereas VitD3 stimulated leptin and DKK2 expression 2- and 4.2-fold, respectively, under
normoxia, it stimulated their expression by 28- and 6.2-fold, respectively, under hypoxia (P <0.05). The hypoxia-
induced leptin production was confirmed by ELISA, particularly in the presence of VitD3 (P <0.02). Compared to Obs
incubated in the presence of scramble siRNAs, siHif-2α inhibited VitD3-stimulated leptin mRNA and protein levels by
70% (P =0.004) and 60% (P <0.02), respectively, whereas it failed to significantly alter the expression of DKK2. siHif-
1α has no effect on these genes. Immunoblot analysis showed that VitD3 greatly stabilized Hif-2α under hypoxic
conditions. The increase in leptin expression under hypoxia was also regulated, by p38 MAPK (P <0.03) and
phosphoinositide 3-kinase (P <0.05). We found that the expression of leptin and DKK2 were not related to each
other under hypoxia.
Conclusions: Hypoxic conditions via Hif-2 regulation trigger Obs to produce leptin, particularly under VitD3 stimulation,
whereas DKK2 is regulated mainly by VitD3 rather than hypoxia.* Correspondence: pascal.reboul@univ-lorraine.fr
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Osteoarthritis (OA) is considered a systemic and heteroge-
neous disease. The endpoint of OA is cartilage degradation,
which is associated with and/or preceded by subchondral
bone alterations [1] and synovial membrane inflammation
[2]. The chronological events of these phenomena are still
being debated in the literature, although recent develop-
ments emphasize the pathophysiological role of subchon-
dral bone [3]. In OA, it would appear that the extracellular
matrix of both cartilage and subchondral bone are altered
[4,5]. Early-stage OA increases remodelling and bone loss,
whereas late-stage OA decreases remodelling and increases
subchondral densification. Both stages are important com-
ponents of the pathogenic process that leads to OA lesions
[3]. In regard to subchondral bone changes, modifications
of vascularization parameters have been suspected. The
subchondral region of long bones is particularly vascu-
larised, indicating high nutrient supply [6] not only for
bone cells but also for delivering nutrients to the chondro-
cytes of the deep layers of articular cartilage [7]. Therefore,
the epiphyses are at risk of circulatory insufficiency. Al-
though vascularization of the subchondral bone plate
seems to increase during OA progression [8,9] and there
are occurrences of numerous microchannels through the
osteochondral plate [10], the literature contains evidence
of blood flow disturbances in this region. For instance, ven-
ous stasis [11] was noted a long time ago and more re-
cently was confirmed with dynamic contrast-enhanced
magnetic resonance imaging (MRI) [12] and positron elec-
tron transfer [13]. Venous stasis sometimes leads to
intraosseous hypertension in patients with OA [11]. Fur-
thermore, similar blood flow disturbances were demon-
strated in the subchondral bone medial plateau of guinea
pigs, which develop spontaneous knee OA [14]. In this
model, the observation of outflow obstruction preceding
bone and cartilage OA lesions lends support to a key role
of abnormal vascularization of OA bone tissues. These per-
fusion abnormalities have also been associated with osteo-
necrosis and bone marrow lesions [12], which are dynamic
episodes visualised by MRI often predictive of progressive
OA for these patients [15-18]. Hence, this altered OA sub-
chondral bone vascularization leads to ischemic episodes
associated with hypoxic conditions [11,19,20]. Interest-
ingly, the presence of carbonic anhydrase IX, a recognized
hypoxia biomarker, has recently been demonstrated in
osteoarthritic bone [21]. Hypoxia has been shown to drive
several pathways in bone, such as growth [22], regener-
ation and disease [23,24], as well as the maintenance of
haematopoiesis [25]. Recently, Chang et al. demonstrated
that hypoxia induced vascular endothelial growth factor
(VEGF) expression as well as other genes involved in bone
vasculature in OA osteoblasts (Obs) [21]. In addition, they
suggested that hypoxia modifies the OA Ob phenotype.
Key mediators—namely, hypoxia-inducible transcriptionfactors (Hifs)—play a vital role during these hypoxia. Hif
heterodimers are composed of an oxygen-sensitive α-
subunit and a constitutively expressed β-subunit. Hif-1α
and Hif-2α are the best characterized α isoforms [26].
During hypoxia, an accumulated Hif-α protein translo-
cates to the nucleus and forms a dimer with Hif-β.
Among several factors potentially involved in OA patho-
genesis, leptin and dickkopf-related protein 2 (DKK2) are
good candidates [27-31], and their local production by
Obs isolated from the subchondral bone seems to be im-
portant [29,31,32]. Leptin levels in the synovial fluid are
greater in OA patients than that in healthy people, and
this adipokine exerts a proinflammatory effect in synovial
fibroblasts [33]. The level of leptin also increases in cartil-
age with the severity of OA as well as in subchondral bone
[29,34]. In fact, leptin might act as a proinflammatory fac-
tor on cartilage metabolism and exerts a catabolic effect
on OA joints [35]. Interestingly, members of our collab-
orative group previously reported that DKK2 is increased
fourfold in OA Obs and that it also inhibits Wnt/β-catenin
signalling, suggesting that DKK2 participates in the altered
phenotype of OA Obs and to the reduced mineralization
[31]. The regulation of leptin gene by hypoxia seems to
be cell-specific [36-38] or cell environment–dependent
[39,40], whereas DKK2 has not yet been described as a po-
tential target of Hifs. Therefore, in the present study, we
investigated this hypothesis in experiments using human
OA Obs isolated from the subchondral bone plate.
Methods
Patients and clinical parameters
Tibial plateaus were obtained from patients with OA
who were undergoing total knee replacement surgery. A
total of 14 patients (age 69.1 ± 8.7 years; BMI 31.4 ± 9.6;
10 women and 4 men) who had OA according to the rec-
ognized clinical criteria of the American College of
Rheumatology were included [41]. All specimen collection
and all procedures were approved by the ethics committee
of the Nancy University Hospital (CHU) (agreement UF
9607-CPRC 2005) and conducted in conformity with the
Declaration of Helsinki principles. Written informed
consent was obtained from all participants as men-
tioned elsewhere [42].
Preparation of primary subchondral bone cell cultures
Isolation of the subchondral bone plate and preparation of
Ob cultures were performed using medial and lateral tibial
plateaus, where bone sclerosis is observed as described pre-
viously [43]. Cells were passaged once at 25,000 cells/cm2
and grown for 5 days in Dulbecco’s modified Eagle’s
medium/F12 containing 10% foetal bovine serum (FBS)
and a 1% penicillin-streptomycin mixture. Confluent cells
were then preconditioned for 24 hours with the same
medium containing 0.5% FBS and then incubated in the
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Sigma-Aldrich, St-Quentin Fallavier, France) or of the ve-
hicle (ethanol 96%, 1 μl/ml) under normoxia (20% O2) or
hypoxia (2% O2) for different periods of time as speci-
fied in the experiments. Supernatants were collected at
the end of the incubation period and kept at −20°C
prior to assays.
RT-PCR assays
Total RNA was extracted from Obs using the RNeasy
Mini Kit (QIAGEN, Courtaboeuf, France) according to
the manufacturer’s instructions. Gene expression was ana-
lysed by quantitative real-time PCR (StepOnePlus Real-
Time PCR System; Applied Biosystems, St-Aubin, France)
using iTaq Universal SYBR Green Supermix (Bio-Rad
Laboratories, Marnes la Coquette, France) according to
the manufacturer’s protocol. The gene-specific primer
pairs are given in Table 1. RP29 served as a housekeeping
gene.
Western blot analysis
Cell extracts were loaded onto 4–20% SDS-PAGE precast
gels (Bio-Rad Laboratories), and Western immunoblot
analysis and signal detection were performed as previously
described [44]. As primary antibodies, we used a mouse
anti-Hif-2α monoclonal antibody at a dilution of 1:1,000
(Thermo Scientific, Rockford, IL, USA), a rabbit anti-Hif-
1α polyclonal antibody at a dilution of 1:1,000 (NovusTable 1 Oligonucleotides used for real-time RT-PCRa
Gene Sequence
RP29 S 5′-GGG TC
AS 5′-CAG AC
Leptin S 5′-GGC TT
AS 5′-GGA TA
DKK2 S 5′-GGG TT
AS 5′-TGG CT












S, sense; AS, Antisense; DKK2, Dickkopf-related protein 2; Hif-2, Hypoxia-inducible fa
growth factor α.Biologicals Interchim, Montluçon, France) and a rabbit
anti-actin antibody at a dilution of 1:8,000 (Sigma-Al-
drich). Anti-mouse and anti-rabbit horseradish peroxid-
ase–conjugated immunoglobulin G secondary antibodies
were used at a dilution of 1:10,000 (Thermo Scientific).
Inhibition of Hif-1α and Hif-2α expression by
RNA silencing
Silencing RNAs (siRNAs) were obtained from Eurogen-
tec (Liège, Belgium), and we followed the manufacturer’s
directions for their preparation. OA Obs were split into
24-well plates at 25,000 cells/cm2 to obtain 50% conflu-
ence at the time of transfection. siHif-2α, siHif-1α or
scramble siRNA (siScr; basal condition) was added to
OA Obs at a final concentration of 10 nM in the pres-
ence of 2 μl of INTERFERin™ reagent (Polyplus Trans-
fection, Strasbourg, France). After 24 hours, cells were
starved with medium containing 0.5% FBS for 24 hours
and then treated with 50 nM VitD3 or ethanol under hyp-
oxic conditions for 6, 24 or 48 hours. Conditioned media
were collected at the end of the incubation period and
kept at −20°C prior to assays. Cells were harvested in ei-
ther Buffer RLT Plus lysis buffer with β-mercaptoethanol
(QIAGEN) for RNA extraction or in Laemmli 1× buffer
for protein extraction. These experiments were repro-
duced with Obs from 5 different patients; (n= 5). Experi-
ments with siRNAs targeting leptin or DKK2 were
performed for a 48-hour period under similar hypoxic5′-3′ Gene ID
A CCA GCA GCT CGA GA-3′ NM_001032.3
A CGA CAA GAG CGA GA-3′
T GGC CCT ATC TTT TC-3′ NM_000230.2
A GGT CAG GAT GGG GT-3′
T TGC TGT GCT CGT-3′ NM_014421.2
T TGG AGG AGT AGG TG-3′
C GCA AGT CCT CAA AG-3′ NM_181054.2











ctor 2; TGF-β1, Transforming growth factor β1; VEGFα, Vascular endothelial
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well plates were transfected with 500 ng of a Hif-1 re-
sponse element Renilla luciferase reporter construct
(SwitchGear Genomics, Carlsbad, CA, USA) in the pres-
ence of a polycationic transfection reagent (ExGen 500;
Euromedex, Strasbourg, France) according to the manu-
facturer’s recommendations (in triplicates for each condi-
tion; n =4). Renilla luciferase activity was measured after
36-hour incubation of Obs in hypoxic conditions.Inhibition of p40/p42 MAPK, p38 MAPK and
phosphoinositide 3-kinase
OA Obs (n =5) were treated with p40/p42 inhibitor
(10 μM PD98059; Calbiochem, Darmstadt, Germany), p38
inhibitor (5 μM SB203580; Calbiochem) or phosphoinosi-
tide 3-kinase (PI3K) inhibitor (5 μM LY294002; Calbio-
chem), or with vehicle (1 μl/1,000 μl dimethyl sulphoxide),
under normoxia 1 hour before addition of 50 nM VitD3 or
ethanol and incubation under hypoxia for 48 hours. Con-
ditioned media were collected at the end of the incubation
period for evaluation of leptin production (see next sub-
section), and cells were lysed in 0.5% SDS for protein
quantitation by bicinchoninic acid assay.Evaluation of leptin production
Leptin was evaluated in Obs-conditioned media using
a human Quantikine immunoassay (R&D Systems,
Minneapolis, MN, USA). The sensitivity of the assay is
7.8 pg/ml, and the intra-assay precision is 3.2 ± 0.2%.Statistical analysis
Data are expressed as mean ± SEM. Statistical analyses
were performed using either one-way analysis of variance
followed by Dunnett’s multiple comparisons post hoc test
or a t-test using GraphPad Prism 5 (GraphPad Software,
La Jolla, CA, USA). P-values <0.05 between different ex-
perimental groups were considered significant.Figure 1 Alteration of the expression of selective gene targets under
24 hours either under normoxia (Nox) or hypoxia (Hox; 2% O2). Vascular en
factor β1 (TGFbeta) (C). *P <0.05, statistically significant compared to Nox (nResults
Expression of biomarkers of hypoxia in cultured
osteoarthritis osteoblasts
We first sought to determine whether hypoxia would
affect OA Obs by evaluating the expression of selective
gene targets. Figures 1A to 1C show that our experimental
conditions stimulated expression of genes known to be in-
duced by hypoxia (namely,VEGF (P <0.05) (Figure 1A), Sirt1
(P <0.05) (Figure 1B) and TGF-β1 P <0.05) (Figure 1C)),
thus validating their relevance to hypoxia.
Expression of DKK2 and leptin in osteoarthritis
osteoblasts under hypoxia
We next tested whether human OA Obs would still be re-
sponsive to VitD3 under hypoxia by analysing osteocalcin
(OCN) expression, a late marker gene of Ob differenti-
ation, by real-time RT-PCR (n =9). VitD3 increased OCN
expression about 200-fold under both normoxia (P <0.05)
and hypoxia (P =0.003) without any significant differences
after 24 hours (Figure 2A). Of note, however, is that, in
the absence of VitD3, hypoxia alone stimulated the expres-
sion of OCN about sixfold (P <0.05). We next evaluated
whether hypoxia would lead OA Obs to produce variable
levels of DKK2 (Figure 2B) and leptin (Figures 2C and
2D), which have been related to OA pathogenesis in bone.
Hypoxia stimulated the expression of DKK2 only 1.8-fold
(n =7, P <0.05), whereas VitD3 stimulated the expression
of DKK2 about 4-fold under normoxia (P <0.05) and 3-
fold under hypoxia (P <0.02). Hypoxia stimulated the ex-
pression of leptin sevenfold (n =10, P <0.05). Compared to
control (hypoxia without VitD3), VitD3 stimulated leptin
expression twofold under normoxic conditions (P <0.05)
and fourfold under hypoxia (P <0.03) (Figure 2C). Hence,
the combined effect of VitD3 and hypoxia stimulated lep-
tin and DKK2 production 28- and 6.2-fold, respectively,
compared to control under normoxia. As hypoxia was
more powerful in enhancing leptin expression in OA
Obs, we next evaluated the capacity of OA Obs to
synthesize leptin. When we assessed leptin productionhypoxia. Human osteoarthritis (OA) osteoblasts were incubated for
dothelial growth factor (VEGF) (A), Sirt1 (B) and transforming growth
=4 to 6 experiments).
Figure 2 Osteocalcin, dickkopf-related protein 2 and leptin expression under hypoxic conditions. Human osteoarthritis osteoblasts were
incubated for 24 hours (RT-PCR experiments) to determine the expression of osteocalcin (A), dickkopf-related protein 2 (DKK2) (B) and leptin (C) (n =7
to 10 experiments), or for 48 hours (enzyme-linked immunosorbent assay experiments) to measure leptin production (D) (n =8 experiments) under
either normoxia or hypoxia (2% O2) in the presence of 50 nM 1,25-dihydroxyvitamin D3 (D3) or vehicle (0.1% ethanol; EtOH). *P <0.05. ND, Not detectable.
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able level under normoxia without concentrating the
conditioned media, whereas hypoxia led to detectable
leptin production (Figure 2D). This hypoxia-induced
production was further stimulated twofold with VitD3
(P <0.02) (Figure 2D).
Regulation of the expression of DKK2 and leptin in
osteoarthritis osteoblasts under hypoxia using siHif-1α
and siHif-2α
We first verified that siHif-1α and siHif-2α decreased
the expression of their respective target genes under
hypoxia using RT-PCR (n =5). Compared with siScr con-
ditions, siHif-1α decreased its own expression by almost
60% under basal conditions (P <0.03) and with VitD3
stimulation (P <0.04) (Figure 3A) without affecting Hif-
2α mRNA levels. Under both conditions, siHif-2α de-
creased its own expression by 70% compared to the level
of siScr (P <0.006 for basal conditions and P <0.008 with
VitD3 stimulation) (Figure 3B) without affecting Hif-1α
expression. We next evaluated whether DKK2 and leptin
expression would be modified under hypoxia using
siHif-1α and siHif-2α. Neither siScr, siHif-1α nor siHif-
2α had any significant effect on the expression of DKK2(Figure 3C). Leptin expression was slightly, but not signifi-
cantly, downregulated in the presence of siScr under basal
conditions, whereas it remained unchanged in the presence
of VitD3 (Figure 3D). No significant inhibition of leptin ex-
pression was observed using siHif-1α alone, although a
trend towards a decrease was noticed. Conversely, siHif-2α
inhibited leptin expression by 50% compared to siScr
(P <0.05) under basal conditions and by 67% with VitD3 in-
cubation (P =0.004) (Figure 3D). We next verified the im-
pact of Hif silencing on leptin protein levels. After 48 hours
under hypoxia, no significant differences in leptin produc-
tion were observed between siScr conditions or without
any siRNA in the absence of VitD3, although a trend to-
wards decreasing leptin levels was observed with siHif-2α
(Figure 3E). Conversely, in the presence of VitD3, siHif-2α
decreased leptin production significantly by 60% compared
to siScr (P <0.02), whereas siHif-1α did not.
Signalling pathways involved in leptin production
According to the above-described results, VitD3-induced lep-
tin production was regulated mainly by Hif-2α. Therefore,
we next investigated whether VitD3 could increase this
protein in Obs. As expected, we found by immunoblotting
that hypoxia increased Hif-2α stabilization. Moreover, this
Figure 3 Role of Hif-1 and Hif-2 in dickkopf-related protein 2 and leptin expression during hypoxia. After following the RNA silencing
protocol described in the Methods section, human osteoarthritis osteoblasts were incubated for 24 hours (RT-PCR experiments) to determine the
expression of hypoxia-inducible factor 1 (Hif-1) (A), Hif-2 (B), dickkopf-related protein 2 (DKK2) (C) and leptin (D) (n =5 experiments), or for
48 hours to measure leptin production (E) (n =5 experiments), under hypoxia in the presence of 50 nM 1,25-dihydroxyvitamin D3 (D3) or 0.1%
EtOH. SiSrc, Scrambled silencing RNA (control). *P <0.05.
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(Figure 4A) and peaked after 6 hours of hypoxia (kinetics
not shown). Although Hif-1 does not seem to be involved
in leptin production, we investigated whether this factor
was also activated. Our results demonstrated that hypoxia
also stabilized Hif-1 and that this stabilization was slightly
enhanced by VitD3, but was prevented in the presence of
siHif-1 (Figure 4B). In addition, by using a Hif-1α response
element construction, we discovered that the stabilized
Hif-1 protein was active under our experimental condi-
tions of hypoxia, whereas treatments with siHif-1 de-
creased the hypoxia-induced Renilla luciferase activity
(Figure 4C). Thus, these results reinforce those shown in
Figure 3, indicating that, although Hif-1α was active, Hif-2
was responsible for the increase in leptin under hypoxia.Next, using selective kinase inhibitors, we investigated
whether pathways other than Hifs could be involved in lep-
tin production. Inhibition of p38 MAPK and PI3K for
48 hours under hypoxia significantly decreased both basal
(P <0.001 and P <0.006, respectively) and VitD3-dependent
leptin production by OA Obs (P <0.03 and P <0.05, re-
spectively). Inhibition of the p40/42 kinase pathway by
PD98059 marginally decreased leptin production without
VitD3 (P <0.02), but had no significant effect when VitD3
was present (Figure 4D).
Search for crosstalk between leptin and DKK2
We next evaluated if the expression of leptin and DKK2
could be linked under hypoxia. Inhibiting leptin expression
with siLept (P <0.03) (Figure 5A) failed to reduce the
Figure 4 Signalling pathways of hypoxia- and 1,25-dihydroxyvitamin D3-stimulated leptin production. (A) Cells were treated with EtOH
(−) or 1,25-dihydroxyvitamin D3 (VitD3; +) and immediately incubated under normoxia or hypoxia. Immunoblot illustrating hypoxia-inducible
factor 2 (Hif-2) stabilization representative of three independent experiments is shown. (B) Cells were treated with scrambled silencing RNA (siScr)
or siHif-1 for 24 hours, then with EtOH (−) or VitD3 (+) and immediately incubated under normoxia or hypoxia for 6 hours. Immunoblot illustrating Hif-1
stabilization representative of four independent experiments is shown. (C) Cells were treated with siScr or siHif-1 for 24 hours, then transfected with a
Hif-1 response element driving Renilla luciferase gene and incubated under hypoxia for 36 hours. *P <0.05. (D) Cells were pretreated with vehicle (0.1%
dimethyl sulphoxide) or different inhibitors for 1 hour under normoxia, then EtOH or VitD3 was added and cells were immediately incubated under
hypoxia for 48 hours (n =5 experiments). PD98059, inhibitor of mitogen-activated protein kinase kinase (MEK); SB203580, p38 mitogen-activated kinase
inhibitor; LY294002, Phosphoinositide 3-kinase inhibitor. *P <0.05. #Significant compared to vehicle (EtOH).
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DKK2 with siDKK2 reduced the expression of DKK2
(P <0.001) (Figure 5B), but had no effect on leptin ex-
pression (Figure 5A).Discussion
In the present study, we show that human OA Obs pro-
duced higher amounts of leptin under hypoxia than
under normoxia. Production leptin was further in-
creased in the presence of VitD3. In addition, DKK2, an-
other gene with disturbed expression in OA, was
upregulated under hypoxia. The regulation of leptin was
mainly Hif-2α-dependent, because the knock-down of
Hif-1α expression failed to affect leptin expression. Hyp-
oxic regulation of leptin is also under the control of p38
MAPK and PI3K signalling pathways. Unlike leptin, the
direct regulation of DKK2 seemed to be independent of ei-
ther Hif-1α or Hif-2α. Also, under hypoxia, leptin did
not alter the expression of DKK2, whereas, recipro-
cally, DKK2 did not alter the expression of leptin.
This indicates that hypoxia per se was responsible for
their respective increase and that neither leptin nor
DKK2 can regulate each other.Vascularization was reported to be increased in the
subchondral bone plate during early to late stages of
OA [7,8]. In other studies, researchers found that bone
hypertension and vascular stasis generated hypoxia in OA
[11,12,20]. Interestingly, in the spontaneous OA guinea
pig model, changes in perfusion outflow of gadolinium
with diethylenetriaminepentaacetic acid at 6 to 9 months
temporally preceded and spatially colocalized with both
cartilage degradation and bone remodelling in the medial
tibial plateau [12]. Measuring real partial oxygen pressure
in bone is difficult to assess, and concentrations of 3% to
7% have been described [45,46]. Meanwhile, Hif signalling
has been demonstrated to intervene during both normal
bone physiology and pathologies, indicating that values
under 3% can be reached [23]. These hypoxic conditions
could thus explain why OA Obs produce higher levels of
VEGF [47] and hepatocyte growth factor [48], particularly
in the sclerotic zones [49]. Consistent with these findings,
our results show that hypoxia directly regulates VEGF ex-
pression by OA Obs (Figure 1A). Nevertheless, hypoxia
could modify the phenotype of OA Obs [21], and, as de-
scribed previously, Hif-1α and Hif-2α are the main effec-
tors in the modulation of gene transcription under
hypoxic conditions [23].
Figure 5 Link between leptin and dickkopf-related protein 2 expression under hypoxia. Human osteoarthritis osteoblasts were incubated
for 24 hours under hypoxia (2% O2) in the presence of 50 nM 1,25-dihydroxyvitamin D3 (D3) to optimize leptin and dickkopf-related protein 2
(DKK2) production (n =5 or 6 experiments). The RNA silencing protocol described in the Methods section was followed for siDKK2 and siLept.
*Statistically significant vs siScr D3. siScr, Scrambled silencing RNA.
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cated because their transcriptional regulation is not fully
predictive of their protein level. For example, in the
present study, 24-hour incubation with VitD3 induced
Hif-2α expression by almost twofold under normoxia
(data not shown); however, protein stabilization was al-
most undetectable in immunoblot analysis (Figure 4A).
However, after 6 hours of hypoxia, Hif-2α protein was
strongly increased in the presence of VitD3. Similarly,
we observed that VitD3 increased Hif-1α expression. It
was not involved in leptin regulation, however. VitD3
has been reported to be involved in the regulation of
Hif-1α in breast epithelial cells [50], but, to our know-
ledge, the present study is the first one demonstrating
the regulation of Hif-2α by VitD3. Among potential
genes regulated by hypoxia, we paid attention to leptin,
which plays a role in the pathogenesis of OA [29,33].
In preliminary experiments, we found that leptin ex-
pression was similar at 20% and 12% oxygen tension,
followed by a noticeable increase at 7% and a huge
stimulation at 3% and 2% (data not shown). Leptin pro-
duction was also synergistically regulated by hypoxia and
VitD3, and Hif-2α was the main regulator of leptin pro-
duction under hypoxia. Conversely, Hif-1α played almost
no role in leptin regulation in OA Obs. This situation has
also been observed in fibroblast-like synoviocytes in
rheumatoid arthritis [37]. However, the alternate regula-
tion by either Hif-1α or Hif-2α factors might be species-
dependent, because leptin is regulated mainly by Hif-1α
under hypoxic conditions in zebrafish [51].
With regard to the leptin promoter, we found a hypoxia-
responsive element (HRE) site juxtaposed to a potential
vitamin D–responsive element (VDRE) site, which allows
hypothesizing a theoretical cooperative interaction between
VDRE and Hif-2α in a VDRE partnering model, as pro-
posed by Carlberg and Campbell [52]. Therefore, VitD3
could be involved at two levels of leptin regulation, first bystabilizing Hif-2α protein levels and second by directly
interacting with the VDRE present in the leptin promoter
to synergistically stimulate leptin transcription. However,
the presence of HRE and VDRE in the leptin promoter is
probably necessary but not sufficient to presume a potential
activation of transcription, because no synergy of transcrip-
tional activity was noticed in other cell types [36].
We observed that leptin production is strongly regulated
via p38 MAPK and PI3K, although we have not discrimi-
nated whether this regulation directly affected Hif-2α
phosphorylation or targeted other factors. The role of lep-
tin in bone metabolism is controversial [53,54]. However,
in the context of hypoxia, which is known to induce osteo-
cyte apoptosis within a few hours [55,56], the need for
bone remodelling is crucial to maintaining bone health.
Therefore, the coactivation of leptin expression by hypoxia
and VitD3 should be considered a warning signal (that is,
Obs sense oxygen tension), which, when oxygen tension
decreases too drastically, alarms Obs to activate genes able
to promote bone and vascular remodelling. In this con-
text, leptin, which has been shown to increase Ob number
and activity [29,57], as well as osteoclast activity [54,58],
could play a role in remodelling. This type of scenario
could happen, given the presence of defective capillaries
within the subchondral bone plate, as reflected by the
presence of stasis or microemboli, and could potentially
lead to OA if the vasculature is not fully repaired. This
would explain why Obs produce high levels of VEGF in
response to hypoxia [47], as we show in the present study,
leading to a compensatory hypervascularization of the
subchondral bone that might not, however, result in fully
mature functional vessels. If we assume that vasculature
dysfunction plays a role in OA [20], this could explain the
high prevalence of OA in patients who show signs of the
metabolic syndrome, in whom the vascular system is often
affected. If the vasculature fails to be well repaired, sus-
tained amount of leptin could then be produced in the
Bouvard et al. Arthritis Research & Therapy  (2014) 16:459 Page 9 of 11vicinity of the defect, which would lead over time to im-
pairments in leptin signalling, as observed in obese pa-
tients [59]. Therefore, the effects of both the anabolic and
catabolic properties of leptin on bone cannot be fully
achieved, leading to (1) an uncoupling of bone remodel-
ling and, possibly, to sclerosis of the subchondral bone
plate and (2) an abnormal OA Ob phenotype, as previ-
ously described [29]. In addition to the overproduction of
leptin, a combination of hypoxia and VitD3 increased
DKK2 expression, which has also been related to the ab-
normal phenotype of OA Obs [31]. Unlike leptin, the ex-
pression of DKK2 was not significantly repressed by either
Hif-1α or Hif-2α. Hence, as neither siHif-1α nor siHif-2α
altered the expression of DKK2, which was stimulated
under hypoxia, yet another mechanism must be set in
place to regulate the expression of DKK2 under hypoxia.
However, we and others previously demonstrated that
transforming growth factor β1 (TGF-β1) can promote
the expression of leptin in human Obs and rat bone tis-
sue [29,30], as well as the expression of DKK2 in human
primary Obs [31]. We also observed that hypoxia was
able to induce TGF-β1 expression in OA Obs, which
could explain, in part, the links between hypoxia, TGF-
β1, leptin and DKK2 and why the expression of DKK2
could not be directly modulated by siHifs. However, the
intricate relationship between these factors remains to
be fully investigated.
Conclusion
We demonstrate a synergism between hypoxia and
VitD3 in leptin production by human OA Obs, suggesting
that problems in the vasculature of the subchondral bone
could play a role in the development of OA. In this study,
we produced new data confirming the hypothesis of a re-
cently published study [21] in which the researchers found
that hypoxia modulates the Ob phenotype. Vascularization
of the subchondral bone plate during OA needs to be ex-
plored more in depth to gain understanding of the role of
oxygenation in the physiopathology of bone remodelling
in OA.
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